Dr. Edwin Ivan Valdez, MD

Dr. Valdez practices at Dell Seton Medical Center at The University of Texas in Austin, Texas, part of Ascension Health Alliance.

Dr. Valdez's NPI, 1215575568, was assigned on December 17, 2019. Dr. Valdez graduated from Universidad Autonoma de Guadalajara in 2018. Dr. Valdez holds Texas license U3680.

Dr. Valdez's primary practice is Dell Seton Medical Center at the University of Texas, at 601 E 15th Street, Austin, TX 78701 in Travis County. The practice phone is (512) 324-7000. Dr. Valdez also practices at Dell Seton Medical Center at University of Texas, 1500 Red River St, Austin, TX 78701.

Dr. Valdez's primary practice is Dell Seton Medical Center at The University of Texas in Austin, Texas, part of Ascension Health Alliance. Dr. Valdez is also affiliated with St. David's Medical Center. The medical group on file is US Acute Care Solutions. Dmand AI also links Dr. Valdez to 2 more group practices and clinics, 1 clinical lab and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valdez practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Valdez's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Valdez is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Valdez's licenses on file in 2 states: Texas and Illinois.

CMS counts 25 Medicare patients who saw Dr. Valdez in 2024. 68% of them have high blood pressure, and 48% have high cholesterol. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Valdez's median patient age at 67, with 59% women.

In 2024, Dr. Valdez wrote 215 Medicare Part D claims for 103 patients. 91% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $185 in total drug cost. In 2023, CMS named 38 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Valdez for performance year 2024, reported as part of a group. Dr. Valdez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Valdez from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $22.

Dr. Valdez graduated from Universidad Autonoma de Guadalajara in 2018.

Dr. Valdez is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.